+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Coronary Artery Bypass Grafts Market - Global Forecast 2026-2032- Product Image
Coronary Artery Bypass Grafts Market - Global Forecast 2026-2032- Product Image
Sale

Coronary Artery Bypass Grafts Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887530
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Coronary Artery Bypass Grafts Market is projected to reach USD 20.96 Billion in 2026. It is expected to continue growing at a CAGR of 5.43%, reaching USD 28.86 Billion by 2032.

Coronary Artery Bypass Grafts: Executive Summary

Coronary artery bypass grafting (CABG) uses conduit vessels to create alternative routes around narrowed or blocked coronary arteries. The field is shaped by the clinical need to restore myocardial perfusion, improve symptoms, and support treatment of complex coronary artery disease. Relevant graft options include arterial and venous conduits, while procedural decisions depend on anatomy, comorbidities, surgical risk, and the capabilities of the treating center.
Clinical practice increasingly emphasizes evidence-based conduit selection, durable revascularization, coordinated perioperative care, and patient-specific treatment planning. Evaluation should consider graft quality, handling characteristics, patency, infection risk, and compatibility with surgical technique rather than treating the graft as an isolated product.

CABG Is Shifting Toward Durable, Patient-Specific Revascularization

The landscape is changing through broader use of arterial conduits, advances in minimally invasive and robotic-assisted techniques, and more structured comparison of surgery with catheter-based revascularization. Multidisciplinary heart teams increasingly integrate angiographic findings, ventricular function, diabetes status, kidney disease, frailty, and patient preferences when selecting a treatment pathway.
Perioperative improvements also influence outcomes. Enhanced recovery protocols, infection prevention, blood-conservation strategies, improved imaging, and postoperative rehabilitation are becoming important components of the overall CABG pathway. These shifts raise expectations for reliable graft performance while increasing the importance of training, operating-room integration, and longitudinal follow-up.

Artificial Intelligence Is Strengthening Planning, Risk Assessment, and Follow-Up

Artificial intelligence can support CABG care by analyzing imaging, identifying coronary and conduit characteristics, assisting anatomical reconstruction, and helping clinicians stratify perioperative risk. Predictive tools may also aid assessment of complications such as acute kidney injury, prolonged ventilation, infection, readmission, and graft failure when they are trained on representative, clinically validated data.
The most credible applications remain decision-support tools rather than autonomous clinical systems. Effective implementation requires external validation, transparent performance reporting, privacy safeguards, interoperability with electronic health records, and monitoring for demographic or institutional bias. AI can improve workflow and consistency, but final decisions should remain grounded in clinician judgment, guideline-based care, and informed patient consent.

Regional Insights: Access, Surgical Capacity, and Standards Shape Adoption

North America combines advanced cardiac-surgery infrastructure with strong emphasis on outcomes reporting, multidisciplinary decision-making, and technology-assisted procedures. Europe places substantial focus on clinical guidelines, quality assurance, health-system coordination, and equitable access across countries. Asia-Pacific presents wide variation in hospital capacity, specialist availability, referral pathways, and adoption of advanced surgical techniques, alongside significant demand for cardiovascular care.
Latin America is influenced by uneven access to tertiary hospitals, public-private differences, and the availability of cardiac-surgery teams and postoperative services. The Middle East includes highly developed specialist centers as well as systems working to expand local capability and reduce referral dependence. Africa faces major constraints in surgical workforce, equipment, diagnosis, and postoperative support, making capacity building, regional referral networks, and cost-conscious care particularly important.

Group Insights: Economic and Security Blocs Have Uneven CABG Capabilities

ASEAN economies are developing cardiac-care capacity at different speeds, with urban tertiary centers often better equipped than rural or remote facilities. BRICS members span substantial differences in public-health infrastructure, specialist distribution, and domestic medical-device capability, making country-level policy and hospital readiness important. The European Union benefits from shared regulatory and scientific networks, although access and reimbursement practices remain variable among member states.
G7 systems generally have mature cardiac-surgery services, established clinical evidence bases, and stronger data infrastructure, while still addressing aging populations, workforce pressures, and cost containment. GCC countries have invested in advanced hospitals and specialist services but continue to balance domestic capability with international collaboration. NATO members represent diverse health systems; their common emphasis on resilience and continuity of care can support preparedness for supply, workforce, and infrastructure disruptions.

Country Insights: National Health Systems Drive CABG Practice

Australia, Canada, the United Kingdom, and the United States have established cardiac-surgery networks, with ongoing attention to waiting times, rural access, outcomes measurement, and workforce sustainability. France, Germany, Italy, and Spain operate within mature European clinical and regulatory environments, while differences in hospital organization, reimbursement, referral patterns, and regional access influence treatment delivery.
China and India are expanding specialist cardiovascular services while managing substantial geographic and socioeconomic variation. Japan and South Korea combine advanced hospital technology with aging-population pressures and a strong focus on procedural quality. Brazil and Mexico continue to address unequal access between major urban centers and underserved areas. Russia’s CABG environment is shaped by regional variation in specialist capacity, equipment access, and health-system continuity. Across all countries, timely diagnosis, heart-team coordination, conduit quality, postoperative monitoring, and rehabilitation remain central priorities.

Action Priorities for Leaders in the CABG Ecosystem

Industry leaders should prioritize clinically validated graft performance, consistent manufacturing quality, ease of use, and compatibility with contemporary surgical workflows. Product development should address the needs of both high-volume tertiary centers and resource-constrained hospitals, with clear evidence on handling, safety, durability, and patient-relevant outcomes.
Organizations should also strengthen partnerships with cardiac centers, surgeons, regulators, and health systems; invest in training and technical support; and build evidence-generation programs that reflect diverse patient populations. Digital and AI capabilities should be introduced through controlled validation, cybersecurity safeguards, explainability, and post-deployment monitoring. Resilient supply chains, traceability, sustainability, and dependable postoperative support can further improve adoption and long-term clinical value.

Research Methodology: Evidence-Led Assessment of CABG Grafts

This executive summary uses a structured review framework focused on the clinical role of coronary artery bypass grafts, procedural evolution, technology integration, and health-system conditions across the specified geographies and country groupings. The analysis distinguishes established clinical practices from emerging tools and avoids unsupported claims about commercial performance.
Evidence assessment should prioritize peer-reviewed clinical studies, professional guidelines, regulatory materials, hospital-quality reports, government health data, and validated technology evaluations. Findings should be interpreted with attention to study design, population differences, follow-up duration, endpoint definitions, surgical technique, conduit type, and regional variation. AI-related conclusions require additional scrutiny of dataset quality, validation, workflow impact, and safety governance.

Conclusion: Clinical Durability and System Readiness Define Progress

The CABG graft landscape is being shaped by the pursuit of durable revascularization, more individualized treatment selection, improved perioperative pathways, and expanding use of digital decision support. Regional and national differences in surgical capacity, referral systems, financing, and specialist access remain decisive in determining how consistently patients can benefit from these advances.
Leaders that combine robust clinical evidence with surgeon-centered design, workforce development, responsible AI adoption, and resilient delivery systems will be better positioned to support safe and effective CABG care. The central priority is not technology alone, but dependable integration of graft quality, procedural expertise, patient selection, and long-term follow-up.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Coronary Artery Bypass Grafts Market, by Type
7.1. Introduction
7.2. On-Pump
7.3. Off-Pump
8. Coronary Artery Bypass Grafts Market, by Conduit Material Class
8.1. Introduction
8.2. Autologous Tissue
8.2.1. Arterial Conduits
8.2.2. Venous Conduits
8.3. Processed Biologic
8.3.1. Human Allograft
8.3.2. Bovine-Derived Grafts
8.3.3. Porcine-Derived Grafts
8.4. Synthetic Polymer
8.4.1. Expanded PTFE (ePTFE)
8.4.2. Polyethylene Terephthalate (PET/Dacron)
8.4.3. Polyurethane
8.5. Hybrid & Tissue-Engineered
9. Coronary Artery Bypass Grafts Market, by Surgical Access Approach
9.1. Introduction
9.2. Conventional Sternotomy
9.3. Minimally Invasive Direct CABG (MIDCAB)
9.4. Totally Endoscopic Or Robotic-Assisted CABG
9.5. Hybrid Coronary Revascularization (CABG Plus PCI)
10. Coronary Artery Bypass Grafts Market, by Care Delivery Site
10.1. Introduction
10.2. Hospitals
10.3. Specialty Heart Centers
10.4. Ambulatory Surgery Centers
11. Coronary Artery Bypass Grafts Market, by Commercial Route To Market
11.1. Introduction
11.2. Direct Sales To Providers
11.3. Distributors & Dealers
11.4. E-Procurement Platforms
12. Coronary Artery Bypass Grafts Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. Europe
12.4. North America
12.5. Latin America
12.6. Africa
12.7. Middle East
13. Coronary Artery Bypass Grafts Market, by Group
13.1. Introduction
13.2. NATO
13.3. G7
13.4. European Union
13.5. BRICS
13.6. ASEAN
13.7. GCC
14. Coronary Artery Bypass Grafts Market, by Country
14.1. Introduction
14.2. United States
14.3. China
14.4. Germany
14.5. Japan
14.6. India
14.7. United Kingdom
14.8. Canada
14.9. France
14.10. Brazil
14.11. Mexico
14.12. Italy
14.13. Australia
14.14. South Korea
14.15. Russia
14.16. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Medtronic plc
16.2. W. L. Gore & Associates, Inc.
16.3. Terumo Corporation
16.4. Getinge AB
16.5. Becton, Dickinson and Company
16.6. Abbott Laboratories
16.7. Artivion, Inc.
16.8. ASAHI INTECC CO., LTD.
16.9. B. Braun SE
16.10. Berlin Heart GmbH
16.11. Humacyte, Inc.
16.12. LeMaitre Vascular, Inc.
16.13. LivaNova PLC
16.14. SB-KAWASUMI LABORATORIES, INC.
16.15. Vascular Graft Solutions Ltd.
16.16. Xeltis B.V.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Coronary Artery Bypass Grafts Market, Years Considered for the Study
FIGURE 2. Global Coronary Artery Bypass Grafts Market, Research Design
FIGURE 3. Global Coronary Artery Bypass Grafts Market, Research Framework
FIGURE 4. Global Coronary Artery Bypass Grafts Market, Data Triangulation
FIGURE 5. Global Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Coronary Artery Bypass Grafts Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Coronary Artery Bypass Grafts Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2025 vs 2032 (%)
FIGURE 9. Global Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2025 vs 2032 (%)
FIGURE 11. Global Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2025 vs 2032 (%)
FIGURE 13. Global Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2025 vs 2032 (%)
FIGURE 15. Global Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Coronary Artery Bypass Grafts Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Coronary Artery Bypass Grafts Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Coronary Artery Bypass Grafts Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Coronary Artery Bypass Grafts Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Coronary Artery Bypass Grafts Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Coronary Artery Bypass Grafts Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Coronary Artery Bypass Grafts Market Segmentation & Coverage
TABLE 2. Global Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 3. Global Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global On-Pump Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global On-Pump Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global On-Pump Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Off-Pump Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Off-Pump Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Off-Pump Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 11. Global Autologous Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Autologous Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Autologous Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Arterial Conduits Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Arterial Conduits Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Arterial Conduits Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Venous Conduits Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Venous Conduits Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Venous Conduits Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Processed Biologic Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Processed Biologic Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Processed Biologic Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Human Allograft Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Human Allograft Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Human Allograft Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Bovine-Derived Grafts Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Bovine-Derived Grafts Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Bovine-Derived Grafts Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Porcine-Derived Grafts Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Porcine-Derived Grafts Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Porcine-Derived Grafts Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Synthetic Polymer Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Synthetic Polymer Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Synthetic Polymer Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Expanded PTFE (ePTFE) Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Expanded PTFE (ePTFE) Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Expanded PTFE (ePTFE) Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Polyethylene Terephthalate (PET/Dacron) Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Polyethylene Terephthalate (PET/Dacron) Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Polyethylene Terephthalate (PET/Dacron) Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Polyurethane Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Polyurethane Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Polyurethane Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Hybrid & Tissue-Engineered Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Hybrid & Tissue-Engineered Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Hybrid & Tissue-Engineered Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 48. Global Conventional Sternotomy Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Conventional Sternotomy Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Conventional Sternotomy Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Minimally Invasive Direct CABG (MIDCAB) Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Minimally Invasive Direct CABG (MIDCAB) Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Minimally Invasive Direct CABG (MIDCAB) Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Totally Endoscopic Or Robotic-Assisted CABG Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Totally Endoscopic Or Robotic-Assisted CABG Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Totally Endoscopic Or Robotic-Assisted CABG Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Hybrid Coronary Revascularization (CABG Plus PCI) Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Hybrid Coronary Revascularization (CABG Plus PCI) Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Hybrid Coronary Revascularization (CABG Plus PCI) Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 61. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Specialty Heart Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Specialty Heart Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Specialty Heart Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Ambulatory Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Ambulatory Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Ambulatory Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 71. Global Direct Sales To Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Direct Sales To Providers Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Direct Sales To Providers Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Distributors & Dealers Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Distributors & Dealers Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Distributors & Dealers Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global E-Procurement Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global E-Procurement Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global E-Procurement Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Coronary Artery Bypass Grafts Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Coronary Artery Bypass Grafts Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 90. Europe Coronary Artery Bypass Grafts Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Europe Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 92. Europe Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 93. Europe Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 94. Europe Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 95. Europe Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 96. Europe Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 97. Europe Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 98. Europe Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 99. North America Coronary Artery Bypass Grafts Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. North America Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 101. North America Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 102. North America Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 103. North America Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 104. North America Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 105. North America Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 106. North America Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 107. North America Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 108. Latin America Coronary Artery Bypass Grafts Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Latin America Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 110. Latin America Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 111. Latin America Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 112. Latin America Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 113. Latin America Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 114. Latin America Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 115. Latin America Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 116. Latin America Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 117. Africa Coronary Artery Bypass Grafts Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Africa Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 119. Africa Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 120. Africa Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 121. Africa Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 122. Africa Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 123. Africa Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 124. Africa Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 125. Africa Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 126. Middle East Coronary Artery Bypass Grafts Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Middle East Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 128. Middle East Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 129. Middle East Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 130. Middle East Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 131. Middle East Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 132. Middle East Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 133. Middle East Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 134. Middle East Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 135. Global Coronary Artery Bypass Grafts Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. NATO Coronary Artery Bypass Grafts Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. NATO Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 138. NATO Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 139. NATO Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 140. NATO Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 141. NATO Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 142. NATO Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 143. NATO Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 144. NATO Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 145. G7 Coronary Artery Bypass Grafts Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. G7 Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 147. G7 Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 148. G7 Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 149. G7 Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 150. G7 Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 151. G7 Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 152. G7 Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 153. G7 Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 154. European Union Coronary Artery Bypass Grafts Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. European Union Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 156. European Union Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 157. European Union Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 158. European Union Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 159. European Union Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 160. European Union Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 161. European Union Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 162. European Union Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 163. BRICS Coronary Artery Bypass Grafts Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. BRICS Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 165. BRICS Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 166. BRICS Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 167. BRICS Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 168. BRICS Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 169. BRICS Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 170. BRICS Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 171. BRICS Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 172. ASEAN Coronary Artery Bypass Grafts Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. ASEAN Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 174. ASEAN Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 175. ASEAN Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 176. ASEAN Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 177. ASEAN Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 178. ASEAN Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 179. ASEAN Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 180. ASEAN Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 181. GCC Coronary Artery Bypass Grafts Market Size, by Group, 2017-2032 (USD Million)
TABLE 182. GCC Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 183. GCC Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 184. GCC Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 185. GCC Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 186. GCC Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 187. GCC Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 188. GCC Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 189. GCC Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 190. Global Coronary Artery Bypass Grafts Market Size, by Country, 2017-2032 (USD Million)
TABLE 191. United States Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 192. United States Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 193. United States Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 194. United States Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 195. United States Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 196. United States Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 197. United States Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 198. United States Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 199. United States Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 200. China Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 201. China Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 202. China Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 203. China Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 204. China Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 205. China Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 206. China Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 207. China Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 208. China Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 209. Germany Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 210. Germany Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 211. Germany Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 212. Germany Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 213. Germany Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 214. Germany Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 215. Germany Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 216. Germany Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 217. Germany Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 218. Japan Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 219. Japan Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 220. Japan Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 221. Japan Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 222. Japan Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 223. Japan Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 224. Japan Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 225. Japan Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 226. Japan Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 227. India Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 228. India Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 229. India Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 230. India Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 231. India Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 232. India Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 233. India Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 234. India Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 235. India Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 236. United Kingdom Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 237. United Kingdom Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 238. United Kingdom Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 239. United Kingdom Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 240. United Kingdom Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 241. United Kingdom Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 242. United Kingdom Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 243. United Kingdom Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 244. United Kingdom Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 245. Canada Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 246. Canada Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 247. Canada Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 248. Canada Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 249. Canada Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 250. Canada Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 251. Canada Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 252. Canada Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 253. Canada Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 254. France Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 255. France Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 256. France Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 257. France Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 258. France Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 259. France Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 260. France Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 261. France Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 262. France Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 263. Brazil Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 264. Brazil Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 265. Brazil Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 266. Brazil Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 267. Brazil Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 268. Brazil Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 269. Brazil Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 270. Brazil Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 271. Brazil Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 272. Mexico Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 273. Mexico Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 274. Mexico Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 275. Mexico Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 276. Mexico Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 277. Mexico Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 278. Mexico Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 279. Mexico Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 280. Mexico Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 281. Italy Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 282. Italy Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 283. Italy Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 284. Italy Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 285. Italy Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 286. Italy Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 287. Italy Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 288. Italy Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 289. Italy Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 290. Australia Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 291. Australia Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 292. Australia Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 293. Australia Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 294. Australia Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 295. Australia Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 296. Australia Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 297. Australia Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 298. Australia Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 299. South Korea Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 300. South Korea Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 301. South Korea Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 302. South Korea Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 303. South Korea Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 304. South Korea Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 305. South Korea Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 306. South Korea Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 307. South Korea Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 308. Russia Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 309. Russia Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 310. Russia Coronary Artery Bypass Grafts Market Size, by Conduit Material Class, 2017-2032 (USD Million)
TABLE 311. Russia Coronary Artery Bypass Grafts Market Size, by Autologous Tissue, 2017-2032 (USD Million)
TABLE 312. Russia Coronary Artery Bypass Grafts Market Size, by Processed Biologic, 2017-2032 (USD Million)
TABLE 313. Russia Coronary Artery Bypass Grafts Market Size, by Synthetic Polymer, 2017-2032 (USD Million)
TABLE 314. Russia Coronary Artery Bypass Grafts Market Size, by Surgical Access Approach, 2017-2032 (USD Million)
TABLE 315. Russia Coronary Artery Bypass Grafts Market Size, by Care Delivery Site, 2017-2032 (USD Million)
TABLE 316. Russia Coronary Artery Bypass Grafts Market Size, by Commercial Route To Market, 2017-2032 (USD Million)
TABLE 317. Spain Coronary Artery Bypass Grafts Market Size, 2017-2032 (USD Million)
TABLE 318. Spain Coronary Artery Bypass Grafts Market Size, by Type, 2017-2032 (USD Million)
TABLE 319. Spain Coronary Artery By

Companies Mentioned

  • Medtronic plc
  • W. L. Gore & Associates, Inc.
  • Terumo Corporation
  • Getinge AB
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • Artivion, Inc.
  • ASAHI INTECC CO., LTD.
  • B. Braun SE
  • Berlin Heart GmbH
  • Humacyte, Inc.
  • LeMaitre Vascular, Inc.
  • LivaNova PLC
  • SB-KAWASUMI LABORATORIES, INC.
  • Vascular Graft Solutions Ltd.
  • Xeltis B.V.

Related Topics

Related Reports

Coronary Artery Bypass Graft Devices Market - Global Forecast 2026-2032 - Product Image

Coronary Artery Bypass Graft Devices Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Coronary Artery Bypass Graft Market Size, Share & Trends Analysis Report by Method, Surgical Procedure, End Use, Region, and Segment Forecasts, 2026-2033 - Product Image

Coronary Artery Bypass Graft Market Size, Share & Trends Analysis Report by Method, Surgical Procedure, End Use, Region, and Segment Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Coronary Artery Bypass Graft Procedures Market Size, Share - Growth Analysis Report and Forecast Trends (2026-2035) - Product Image

Coronary Artery Bypass Graft Procedures Market Size, Share - Growth Analysis Report and Forecast Trends (2026-2035)

  • Report
  • 350 Pages
  • Global
From
Coronary Artery Bypass Grafts (CABG) - Global Strategic Business Report - Product Image

Coronary Artery Bypass Grafts (CABG) - Global Strategic Business Report

  • Report
  • 227 Pages
  • Global
From
Coronary Artery Bypass Grafting - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Coronary Artery Bypass Grafting - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From

About the Coronary Artery Bypass Graft Market

The Coronary Artery Bypass Graft (CABG) market is a subset of the larger surgical procedures market. CABG is a type of surgery used to treat coronary artery disease, a condition in which the arteries that supply blood to the heart become blocked or narrowed. The procedure involves taking a healthy blood vessel from another part of the body, such as the chest, leg, or arm, and using it to bypass the blocked artery. This allows blood to flow more freely to the heart, reducing the risk of a heart attack. CABG is a major procedure, and the market for it is highly competitive. Companies in the market offer a variety of products and services, including medical devices, surgical instruments, and post-operative care. Many of these companies also provide training and education for surgeons and other healthcare professionals. Companies in the CABG market include Medtronic, Johnson & Johnson, Stryker, and Zimmer Biomet. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.